1 – 15 of 16
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
The APC-PCI concentration as an early marker of activation of blood coagulation A study of women on combined oral contraceptives
(
- Contribution to journal › Article
- 2010
-
Mark
APC-PCI complex as new tool for the evaluation of anticoagulant response to endogenous thrombin formation and its sequel in fibrinolysis
(
- Contribution to journal › Published meeting abstract
- 2008
-
Mark
Activated Protein C Protein C Inhibitor Complex in Patients With Abdominal Aortic Aneurysms: Is It Associated With Diameter and Growth Rate?
(
- Contribution to journal › Article
- 2007
-
Mark
An immunochemical method for quantitative determination of latent antithrombin, the reactive center loop-inserted uncleaved form of antithrombin.
(
- Contribution to journal › Article
-
Mark
The APC-PCI complex concentration predicts outcome of aortic surgery.
(
- Contribution to journal › Article
- 2006
-
Mark
The complex between activated protein C and protein C inhibitor: A clinically useful indicator of aortic aneurysms?
(
- Contribution to journal › Article
-
Mark
From gamma-carboxy-glutamate to protein C.
(
- Contribution to journal › Article
-
Mark
Early identification of acute myocardial infarction by activated protein C-protein C inhibitor complex.
(
- Contribution to journal › Article
-
Mark
Activated protein C-protein C inhibitor complex: a new biological marker for aortic aneurysms.
(
- Contribution to journal › Article
-
Mark
The cleaved and latent forms of antithrombin are normal constituents of blood plasma: a quantitative method to measure cleaved antithrombin.
(
- Contribution to journal › Article
- 2005
-
Mark
APC-PCI complex concentration is higher in patients with previous venous thromboembolism with Factor V Leiden.
(
- Contribution to journal › Letter
-
Mark
Post-translational modifications in proteins involved in blood coagulation.
(
- Contribution to journal › Scientific review
- 2003
-
Mark
Functional analysis of the EGF-like domain mutations Pro55Ser and Pro55Leu, which cause mild hemophilia B.
(
- Contribution to journal › Article
-
Mark
Stabilyte (TM) tubes that contain strongly acidic citrate prevent in vitro complex formation between activated protein C and protein C inhibitor
(
- Contribution to journal › Letter
- 2001
-
Mark
Complexes between activated protein C and protein C inhibitor measured with a new method: comparison of performance with other markers of hypercoagulability in the diagnosis of deep vein thrombosis
(
- Contribution to journal › Article